However, in PLC/PRF/5 HCC cell lines with lower phosphorylation of EGFR/MET, the inhibitory effect of EGFR/MET inhibitors was greatly reduced, and secretion of IL-8 could interrupt by EGFR inhibitor was relatively obvious (Fig. 3C). The gene discussed is EGFR; the disease is hepatocellular carcinoma.